-transparent.png){kind=logo}
Thirty-three patients with relapsing or refractory multiple myeloma were treated with 6-Thioguanine (6TG) at a dose of 1 g/M2, with therapy given over four hours every three weeks. The major toxicity seen was myelotoxicity; thrombocytopenia was more commonly noted than neutropenia. One patient achieved a PR, two were clinically improved. 6TG in this short infusion schedule proved to be myelotoxic, but demonstrated little activity in previously treated myeloma patients.
Related Publications
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
June 1992,
American journal of clinical oncology,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
March 1964,
Cancer chemotherapy reports,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
August 1967,
Cancer chemotherapy reports,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
November 1990,
Journal of the National Cancer Institute,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
November 1985,
Cancer treatment reports,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
May 1990,
Investigational new drugs,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
November 1991,
Investigational new drugs,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
January 1994,
Investigational new drugs,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
August 1990,
Investigational new drugs,
M B Edelstein, and
J J Crowley, and
F A Valeriote, and
J D Bonnet, and
J O Carden, and
R C Khanna, and
S E Salmon, and
J S Ungerleider
February 2002,
Investigational new drugs,
